Interplay between COVID-19 and Secukinumab treatment in Spondylarthritis patients during the omicron surge: a retrospective cohort study

Interplay between COVID-19 and Secukinumab treatment in Spondylarthritis patients during the omicron surge: a retrospective cohort study

The objective of this retrospective cohort study was to assess the relationship between Corona Disease 2019 (COVID-19) and Secukinumab treatment in patients with Spondylarthritis (SpA) in China during the omicron surge. Researchers retrieved 1018 medical records of Secukinumab-treated patients betwe...

Full description

Saved in:
Bibliographic Details
Main Authors: Tong Wu, Yanhong Li, Deying Huang, Yinlan Wu, Xiuping Liang, Lu Cheng, Zehui Liao, Fang Xu, Ye Chen, Jing Zhao, Zijing Xia, Chunyu Tan, Yi Liu, Martin Herrmann
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Autoimmunity
Subjects:
Covid-19
SARS-CoV-2
spondylarthritis
IL-17 inhibitors
secukinumab
Online Access:https://www.tandfonline.com/doi/10.1080/08916934.2023.2281242
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.tandfonline.com/doi/10.1080/08916934.2023.2281242

Similar Items